Host Craig Beavers sits down with Kazuhiko Kido, PharmD, a clinical associate professor at the West Virginia University School of Pharmacy, to discuss intravenous iron and its use in patients with heart failure, as well as findings from the FAIR-HF2 clinical trial. Show notes: Anker SD, Friede T, Butler J, et al. Intravenous ferric carboxymaltose in heart failure with iron deficiency. JAMA. 2025;333(22):1965-1976. doi:10.1001/jama.2025.3833 Kido K, Fang W, Broscious R, et al. Evaluation of a pharmacist-provider collaborative clinic for treatment of iron deficiency in patients with heart failure. Am J Health Syst Pharm. 2023;80(19):1326-1335. doi:10.1093/ajhp/zxad149 Kido K, Beavers CJ, Dulnuan K, et al. Management of iron deficiency in heart failure: practical considerations and implementation of evidence-based iron supplementation. JACC Heart Fail. 2024;12(12):1961-1978. doi:10.1016/j.jchf.2024.05.014 Scientific Statement on Diagnosis and Treatment of Iron Deficiency in Heart Failure Released by Heart Failure Society of America. News release. HFSA. May 2, 2023. Accessed June 27, 2025. Antrim A. Enhancing Patient Care in Heart Failure-Related Anemia Through Improved Communication, Monitoring, and Education. Pharmacy Times. March 17, 2025. Accessed June 27, 2025.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.